Marrone Bio Innovations, Inc. (NASDAQ: MBII) Stock Competitors & Peer Comparison
See MBII's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Agricultural Inputs Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MBII and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MBII | $0.80 | -20.19% | 0 | -6.82 | -$0.12 | N/A |
| CTVA | $80.50 | +2.46% | 53.1B | 21.53 | $3.69 | +0.90% |
| CTA-PA | $52.87 | +0.00% | 51.3B | N/A | N/A | +0.90% |
| CTA-PB | $66.74 | +2.39% | 50.8B | N/A | N/A | +0.90% |
| NTR | $74.49 | +5.66% | 35.1B | 14.86 | $4.92 | +3.00% |
| CF | $129.36 | +8.69% | 19.3B | 9.04 | $13.90 | +1.67% |
| MOS | $24.14 | +8.59% | 7.4B | 16.22 | $1.44 | +3.79% |
| ICL | $5.75 | +4.45% | 7.1B | 13.13 | $0.42 | +3.47% |
| SMG | $61.35 | +0.36% | 3.6B | 13.92 | $4.39 | +4.34% |
| FMC | $11.08 | +2.45% | 1.4B | 4.27 | $2.55 | +7.56% |
Stock Comparison
Corteva, Inc. (NYSE: CTVA)
MBII vs CTVA Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, CTVA has a market cap of 53.1B. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while CTVA trades at $80.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas CTVA's P/E ratio is 21.53. In terms of profitability, MBII's ROE is -0.54%, compared to CTVA's ROE of +0.04%. Regarding short-term risk, MBII is more volatile compared to CTVA. This indicates higher risk in terms of short-term price fluctuations for MBII.Check CTVA's competition here
EIDP, Inc. (NYSE: CTA-PA)
MBII vs CTA-PA Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, CTA-PA has a market cap of 51.3B. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while CTA-PA trades at $52.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas CTA-PA's P/E ratio is N/A. In terms of profitability, MBII's ROE is -0.54%, compared to CTA-PA's ROE of +0.04%. Regarding short-term risk, MBII is more volatile compared to CTA-PA. This indicates higher risk in terms of short-term price fluctuations for MBII.Check CTA-PA's competition here
EIDP, Inc. USD 4.50 Cum Pfd Registered Shs (NYSE: CTA-PB)
MBII vs CTA-PB Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, CTA-PB has a market cap of 50.8B. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while CTA-PB trades at $66.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas CTA-PB's P/E ratio is N/A. In terms of profitability, MBII's ROE is -0.54%, compared to CTA-PB's ROE of +0.04%. Regarding short-term risk, MBII is more volatile compared to CTA-PB. This indicates higher risk in terms of short-term price fluctuations for MBII.Check CTA-PB's competition here
Nutrien Ltd. (NYSE: NTR)
MBII vs NTR Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, NTR has a market cap of 35.1B. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while NTR trades at $74.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas NTR's P/E ratio is 14.86. In terms of profitability, MBII's ROE is -0.54%, compared to NTR's ROE of +0.09%. Regarding short-term risk, MBII is more volatile compared to NTR. This indicates higher risk in terms of short-term price fluctuations for MBII.Check NTR's competition here
CF Industries Holdings, Inc. (NYSE: CF)
MBII vs CF Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, CF has a market cap of 19.3B. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while CF trades at $129.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas CF's P/E ratio is 9.04. In terms of profitability, MBII's ROE is -0.54%, compared to CF's ROE of +0.40%. Regarding short-term risk, MBII is more volatile compared to CF. This indicates higher risk in terms of short-term price fluctuations for MBII.Check CF's competition here
The Mosaic Company (NYSE: MOS)
MBII vs MOS Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, MOS has a market cap of 7.4B. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while MOS trades at $24.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas MOS's P/E ratio is 16.22. In terms of profitability, MBII's ROE is -0.54%, compared to MOS's ROE of +0.00%. Regarding short-term risk, MBII is more volatile compared to MOS. This indicates higher risk in terms of short-term price fluctuations for MBII.Check MOS's competition here
ICL Group Ltd (NYSE: ICL)
MBII vs ICL Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, ICL has a market cap of 7.1B. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while ICL trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas ICL's P/E ratio is 13.13. In terms of profitability, MBII's ROE is -0.54%, compared to ICL's ROE of +0.05%. Regarding short-term risk, MBII is more volatile compared to ICL. This indicates higher risk in terms of short-term price fluctuations for MBII.Check ICL's competition here
The Scotts Miracle-Gro Company (NYSE: SMG)
MBII vs SMG Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, SMG has a market cap of 3.6B. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while SMG trades at $61.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas SMG's P/E ratio is 13.92. In terms of profitability, MBII's ROE is -0.54%, compared to SMG's ROE of -0.22%. Regarding short-term risk, MBII is more volatile compared to SMG. This indicates higher risk in terms of short-term price fluctuations for MBII.Check SMG's competition here
FMC Corporation (NYSE: FMC)
MBII vs FMC Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, FMC has a market cap of 1.4B. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while FMC trades at $11.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas FMC's P/E ratio is 4.27. In terms of profitability, MBII's ROE is -0.54%, compared to FMC's ROE of -1.19%. Regarding short-term risk, MBII is more volatile compared to FMC. This indicates higher risk in terms of short-term price fluctuations for MBII.Check FMC's competition here
CVR Partners, LP (NYSE: UAN)
MBII vs UAN Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, UAN has a market cap of 1.3B. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while UAN trades at $124.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas UAN's P/E ratio is 10.82. In terms of profitability, MBII's ROE is -0.54%, compared to UAN's ROE of +0.52%. Regarding short-term risk, MBII is more volatile compared to UAN. This indicates higher risk in terms of short-term price fluctuations for MBII.Check UAN's competition here
Glass House Brands Inc (NYSE: GLAS)
MBII vs GLAS Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, GLAS has a market cap of 737.1M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while GLAS trades at $9.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas GLAS's P/E ratio is -17.01. In terms of profitability, MBII's ROE is -0.54%, compared to GLAS's ROE of N/A. Regarding short-term risk, MBII is more volatile compared to GLAS. This indicates higher risk in terms of short-term price fluctuations for MBII.Check GLAS's competition here
Intrepid Potash, Inc. (NYSE: IPI)
MBII vs IPI Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, IPI has a market cap of 513M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while IPI trades at $38.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas IPI's P/E ratio is 21.46. In terms of profitability, MBII's ROE is -0.54%, compared to IPI's ROE of +0.05%. Regarding short-term risk, MBII is more volatile compared to IPI. This indicates higher risk in terms of short-term price fluctuations for MBII.Check IPI's competition here
Forafric Global PLC (NASDAQ: AFRIW)
MBII vs AFRIW Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, AFRIW has a market cap of 367.5M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while AFRIW trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas AFRIW's P/E ratio is -46.52. In terms of profitability, MBII's ROE is -0.54%, compared to AFRIW's ROE of +0.46%. Regarding short-term risk, MBII is more volatile compared to AFRIW. This indicates higher risk in terms of short-term price fluctuations for MBII.Check AFRIW's competition here
American Vanguard Corporation (NYSE: AVD)
MBII vs AVD Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, AVD has a market cap of 63.8M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while AVD trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas AVD's P/E ratio is -7.69. In terms of profitability, MBII's ROE is -0.54%, compared to AVD's ROE of -0.28%. Regarding short-term risk, MBII is more volatile compared to AVD. This indicates higher risk in terms of short-term price fluctuations for MBII.Check AVD's competition here
Benson Hill, Inc. (NYSE: BHIL-WT)
MBII vs BHIL-WT Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, BHIL-WT has a market cap of 49M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while BHIL-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas BHIL-WT's P/E ratio is N/A. In terms of profitability, MBII's ROE is -0.54%, compared to BHIL-WT's ROE of -0.82%. Regarding short-term risk, MBII is less volatile compared to BHIL-WT. This indicates lower risk in terms of short-term price fluctuations for MBII.Check BHIL-WT's competition here
BioHarvest Sciences Inc. Common Stock (NASDAQ: BHST)
MBII vs BHST Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, BHST has a market cap of 35.3M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while BHST trades at $2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas BHST's P/E ratio is -4.08. In terms of profitability, MBII's ROE is -0.54%, compared to BHST's ROE of -0.58%. Regarding short-term risk, MBII is more volatile compared to BHST. This indicates higher risk in terms of short-term price fluctuations for MBII.Check BHST's competition here
China Green Agriculture, Inc. (NYSE: CGA)
MBII vs CGA Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, CGA has a market cap of 29.3M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while CGA trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas CGA's P/E ratio is -0.98. In terms of profitability, MBII's ROE is -0.54%, compared to CGA's ROE of +0.11%. Regarding short-term risk, MBII is more volatile compared to CGA. This indicates higher risk in terms of short-term price fluctuations for MBII.Check CGA's competition here
Bioceres Crop Solutions Corp. (NASDAQ: BIOX)
MBII vs BIOX Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, BIOX has a market cap of 28.4M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while BIOX trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas BIOX's P/E ratio is -0.42. In terms of profitability, MBII's ROE is -0.54%, compared to BIOX's ROE of -1.54%. Regarding short-term risk, MBII is more volatile compared to BIOX. This indicates higher risk in terms of short-term price fluctuations for MBII.Check BIOX's competition here
Lavoro Limited (NASDAQ: LVRO)
MBII vs LVRO Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, LVRO has a market cap of 15.1M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while LVRO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas LVRO's P/E ratio is -0.03. In terms of profitability, MBII's ROE is -0.54%, compared to LVRO's ROE of +11.90%. Regarding short-term risk, MBII is more volatile compared to LVRO. This indicates higher risk in terms of short-term price fluctuations for MBII.Check LVRO's competition here
Origin Agritech Limited (NASDAQ: SEED)
MBII vs SEED Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, SEED has a market cap of 12.5M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while SEED trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas SEED's P/E ratio is -1.01. In terms of profitability, MBII's ROE is -0.54%, compared to SEED's ROE of +0.80%. Regarding short-term risk, MBII is more volatile compared to SEED. This indicates higher risk in terms of short-term price fluctuations for MBII.Check SEED's competition here
Save Foods, Inc. (NASDAQ: SVFD)
MBII vs SVFD Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, SVFD has a market cap of 4.2M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while SVFD trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas SVFD's P/E ratio is 0.07. In terms of profitability, MBII's ROE is -0.54%, compared to SVFD's ROE of -319.77%. Regarding short-term risk, MBII is more volatile compared to SVFD. This indicates higher risk in terms of short-term price fluctuations for MBII.Check SVFD's competition here
Femto Technologies Inc. (NASDAQ: FMTO)
MBII vs FMTO Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, FMTO has a market cap of 3.1M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while FMTO trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas FMTO's P/E ratio is -0.00. In terms of profitability, MBII's ROE is -0.54%, compared to FMTO's ROE of -2.43%. Regarding short-term risk, MBII is less volatile compared to FMTO. This indicates lower risk in terms of short-term price fluctuations for MBII.Check FMTO's competition here
Benson Hill, Inc. (NYSE: BHIL)
MBII vs BHIL Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, BHIL has a market cap of 1.5M. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while BHIL trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas BHIL's P/E ratio is -0.01. In terms of profitability, MBII's ROE is -0.54%, compared to BHIL's ROE of -0.82%. Regarding short-term risk, MBII is more volatile compared to BHIL. This indicates higher risk in terms of short-term price fluctuations for MBII.Check BHIL's competition here
Arcadia Biosciences, Inc. (NASDAQ: RKDA)
MBII vs RKDA Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, RKDA has a market cap of 715.2K. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while RKDA trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas RKDA's P/E ratio is -0.19. In terms of profitability, MBII's ROE is -0.54%, compared to RKDA's ROE of -3.40%. Regarding short-term risk, MBII is more volatile compared to RKDA. This indicates higher risk in terms of short-term price fluctuations for MBII.Check RKDA's competition here
Yield10 Bioscience, Inc. (NASDAQ: YTEN)
MBII vs YTEN Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, YTEN has a market cap of 345.5K. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while YTEN trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas YTEN's P/E ratio is -0.02. In terms of profitability, MBII's ROE is -0.54%, compared to YTEN's ROE of -15.08%. Regarding short-term risk, MBII is less volatile compared to YTEN. This indicates lower risk in terms of short-term price fluctuations for MBII.Check YTEN's competition here
Nexentis Technologies Inc. (NASDAQ: NXTS)
MBII vs NXTS Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, NXTS has a market cap of 101.9K. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while NXTS trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas NXTS's P/E ratio is -0.04. In terms of profitability, MBII's ROE is -0.54%, compared to NXTS's ROE of -1.61%. Regarding short-term risk, MBII is more volatile compared to NXTS. This indicates higher risk in terms of short-term price fluctuations for MBII.Check NXTS's competition here
Terra Nitrogen Co., L.P. (NYSE: TNH)
MBII vs TNH Comparison August 2026
Marrone Bio Innovations, Inc. (NASDAQ: MBII) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBII stands at 0. In comparison, TNH has a market cap of 0. Regarding current trading prices, MBII is priced at $0.80 on the NASDAQ, while TNH trades at $83.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBII currently has a P/E ratio of -6.82, whereas TNH's P/E ratio is 10.13. In terms of profitability, MBII's ROE is -0.54%, compared to TNH's ROE of +0.43%. Regarding short-term risk, MBII is more volatile compared to TNH. This indicates higher risk in terms of short-term price fluctuations for MBII.Check TNH's competition here